Novartis
Yan Ji is currently a Director at Novartis working as a clinical pharmacology program lead for full development and submission of small molecules and biologics. She previously worked at Eli Lilly, GlaxoSmithKline and Daiichi Sankyo. Yan received her Ph.D. of Pharmaceutical Sciences from State University of New York at Buffalo. She has published >50 manuscripts and abstracts. She is a member of American Society of Clinical Pharmacology and has served on the scientific programming committee and Oncology community leadership.